Comparative analysis of software for physiologically based pharmacokinetic modeling: Simulation, optimization, and sensitivity analysis

被引:17
|
作者
Easterling, MR
Evans, MV
Kenyon, EM
机构
[1] US EPA, NHEERL, ETD, Res Triangle Pk, NC 27711 USA
[2] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC USA
来源
TOXICOLOGY METHODS | 2000年 / 10卷 / 03期
关键词
PBPK modeling; sensitivity analysis; simulation software;
D O I
10.1080/10517230050121615
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Historically, a number of different software packages running on a variety of hardware platforms have been used for model simulation. SimuSolv found wide use because of its broad capabilities, including optimization, statistical analysis, and formalized sensitivity analysis as well as the capacity to incorporate user-supplied subroutines. However in the early 1990s, SimuSolv development ceased and a final version was released in 1999. Thus SimuSolv will not be developed for newer platforms and operating systems. In this article, we compare and contrast the use of SimuSolv and Matlab (The MathWorks, Natick, MA) for physiologically based pharmacokinetic (PBPK) model implementation with respect to parameter estimation (optimization) and sensitivity analysis using a PBPK model for trichloroethylene (TCE). In both packages, it is possible to code PBPK models, run simulations, estimate parameters, and do sensitivity analysis. The hey difference is the additional programming required in Matlab. Since Matlab does not have built-in estimation and sensitivity routines, it was necessary to write them for the Matlab TCE model. Additionally, Matlab handles flow control differently from SimuSolv, so the model code is written in a different order than for SimuSolv. In spite of the additional coding requirements, Matlab is a well-supported and mathematically oriented simulation software package that is clearly suitable for application to PBPK modeling. All of the modeling tasks done in SimuSolv could also be done readily in Matlab. Most of the comparisons made to SimuSolv also carry over to ACSL-Tox, however ACSL-Tox calculates some sensitivity coefficients very differently from the way they are defined in SimuSolv. Future development of art interpreter for Matlab would make modeling, sensitivity analysis, and parameter estimation less programming-intensive.
引用
收藏
页码:203 / 229
页数:27
相关论文
共 50 条
  • [21] Global sensitivity analysis of Open Systems Pharmacology Suite physiologically based pharmacokinetic models
    Najjar, Abdulkarim
    Hamadeh, Abdullah
    Krause, Sophia
    Schepky, Andreas
    Edginton, Andrea
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (12): : 2052 - 2067
  • [22] POPULATION PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING AND SIMULATION OF INTERETHNIC DIFFERENCES IN PHARMACOKINETICS
    Inoue, Shin-ichi
    DRUG METABOLISM REVIEWS, 2015, 47 : 30 - 31
  • [23] Physiologically based pharmacokinetic (PBPK) modeling and simulation in drug discovery and development
    Shaik, Abdul Naveed
    Khan, Ansar Ali
    ADMET AND DMPK, 2019, 7 (01): : 1 - 3
  • [24] Physiologically based pharmacokinetic modeling and simulation of cannabinoids in human plasma and tissues
    Liu, Yitong
    Sprando, Robert L.
    JOURNAL OF APPLIED TOXICOLOGY, 2023, 43 (04) : 589 - 598
  • [25] Physiologically Based Pharmacokinetic Modeling of Nanoparticles
    Lu, Mingguang
    Al-Jamal, Khuloud T.
    Kostarelos, Kostas
    Reineke, Joshua
    ACS NANO, 2010, 4 (11) : 6303 - 6317
  • [26] Physiologically Based Pharmacokinetic Modeling of Palbociclib
    Yu, Yanke
    Loi, Cho-Ming
    Hoffman, Justin
    Wang, Diane
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (02): : 173 - 184
  • [27] A Comparative Analysis of Physiologically Based Pharmacokinetic Models for Human Immunodeficiency Virus and Tuberculosis Infections
    Mtshali, Sinenhlanhla
    Jacobs, Byron A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (09)
  • [28] Physiologically Based Pharmacokinetic Modeling of Nanoparticles
    Yuan, Dongfen
    He, Hua
    Wu, Yun
    Fan, Jianghong
    Cao, Yanguang
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 108 (01) : 58 - 72
  • [29] Considerations and Caveats when Applying Global Sensitivity Analysis Methods to Physiologically Based Pharmacokinetic Models
    Dan Liu
    Linzhong Li
    Amin Rostami-Hodjegan
    Frederic Y. Bois
    Masoud Jamei
    The AAPS Journal, 22
  • [30] Considerations and Caveats when Applying Global Sensitivity Analysis Methods to Physiologically Based Pharmacokinetic Models
    Liu, Dan
    Li, Linzhong
    Rostami-Hodjegan, Amin
    Bois, Frederic Y.
    Jamei, Masoud
    AAPS JOURNAL, 2020, 22 (05):